Search research articles
Contact Us
Filters
Showing results (131-140 of 179) with videos related to
Page
of 18
Sort By:
The Lancet. Oncology
|
July 6, 2017
From class waivers to precision medicine in paediatric oncology
Andrew D J Pearson, Stefan M Pfister, Andre Baruchel, et al.
Expert Review of Anticancer Therapy
|
July 12, 2023
Neurotrophic tropomyosin receptor kinase (NTRK) fusion positive tumors: a historical cohort analysis
Lauriane Lemelle, Delphine Guillemot, Anne-Laure Hermann, et al.
International Journal of Radiation Oncology, Biology, Physics
|
July 4, 2021
The Impact of Radiation Therapy in Children and Adolescents With Metastatic Rhabdomyosarcoma
Alison L Cameron, Markus C Elze, Michela Casanova, et al.
The Lancet. Oncology
|
December 9, 2019
Pembrolizumab in paediatric patients with advanced melanoma or a PD-L1-positive, advanced, relapsed, or refractory solid tumour or lymphoma (KEYNOTE-051): interim analysis of an open-label, single-arm, phase 1-2 trial
Birgit Geoerger, Hyoung Jin Kang, Michal Yalon-Oren, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
October 26, 2011
R1507, a monoclonal antibody to the insulin-like growth factor 1 receptor, in patients with recurrent or refractory Ewing sarcoma family of tumors: results of a phase II Sarcoma Alliance for Research through Collaboration study
Alberto S Pappo, Shreyaskumar R Patel, John Crowley, et al.
Nature Medicine
|
October 19, 2023
AcSé-ESMART, a European precision cancer medicine proof-of-concept platform trial
Birgit Geoerger, Xavier Paoletti, Francisco Bautista, et al.
European Journal of Cancer (Oxford, England : 1990)
|
March 18, 2020
Outcomes of metastatic non-rhabdomyosarcoma soft tissue sarcomas (NRSTS) treated within the BERNIE study: a randomised, phase II study evaluating the addition of bevacizumab to chemotherapy
Andrea Ferrari, Johannes H M Merks, Julia C Chisholm, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
July 23, 2017
Molecular Screening for Cancer Treatment Optimization (MOSCATO-01) in Pediatric Patients: A Single-Institutional Prospective Molecular Stratification Trial
Anne C Harttrampf, Ludovic Lacroix, Marc Deloger, et al.
Cancer
|
May 7, 2014
A phase 2 trial of R1507, a monoclonal antibody to the insulin-like growth factor-1 receptor (IGF-1R), in patients with recurrent or refractory rhabdomyosarcoma, osteosarcoma, synovial sarcoma, and other soft tissue sarcomas: results of a Sarcoma Alliance for Research Through Collaboration study
Alberto S Pappo, Gilles Vassal, John J Crowley, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
December 5, 2023
Phase I/II Study of the WEE1 Inhibitor Adavosertib (AZD1775) in Combination with Carboplatin in Children with Advanced Malignancies: Arm C of the AcSé-ESMART Trial
Susanne A Gatz, Anne C Harttrampf, Caroline Brard, et al.
Page
of 18
Search research articles
Search
Showing results (131-140 of 179) with videos related to
Sort By:
Page
of 18
The Lancet. Oncology
|
July 6, 2017
From class waivers to precision medicine in paediatric oncology
Andrew D J Pearson, Stefan M Pfister, Andre Baruchel, et al.
Expert Review of Anticancer Therapy
|
July 12, 2023
Neurotrophic tropomyosin receptor kinase (NTRK) fusion positive tumors: a historical cohort analysis
Lauriane Lemelle, Delphine Guillemot, Anne-Laure Hermann, et al.
International Journal of Radiation Oncology, Biology, Physics
|
July 4, 2021
The Impact of Radiation Therapy in Children and Adolescents With Metastatic Rhabdomyosarcoma
Alison L Cameron, Markus C Elze, Michela Casanova, et al.
The Lancet. Oncology
|
December 9, 2019
Pembrolizumab in paediatric patients with advanced melanoma or a PD-L1-positive, advanced, relapsed, or refractory solid tumour or lymphoma (KEYNOTE-051): interim analysis of an open-label, single-arm, phase 1-2 trial
Birgit Geoerger, Hyoung Jin Kang, Michal Yalon-Oren, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
October 26, 2011
R1507, a monoclonal antibody to the insulin-like growth factor 1 receptor, in patients with recurrent or refractory Ewing sarcoma family of tumors: results of a phase II Sarcoma Alliance for Research through Collaboration study
Alberto S Pappo, Shreyaskumar R Patel, John Crowley, et al.
Nature Medicine
|
October 19, 2023
AcSé-ESMART, a European precision cancer medicine proof-of-concept platform trial
Birgit Geoerger, Xavier Paoletti, Francisco Bautista, et al.
European Journal of Cancer (Oxford, England : 1990)
|
March 18, 2020
Outcomes of metastatic non-rhabdomyosarcoma soft tissue sarcomas (NRSTS) treated within the BERNIE study: a randomised, phase II study evaluating the addition of bevacizumab to chemotherapy
Andrea Ferrari, Johannes H M Merks, Julia C Chisholm, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
July 23, 2017
Molecular Screening for Cancer Treatment Optimization (MOSCATO-01) in Pediatric Patients: A Single-Institutional Prospective Molecular Stratification Trial
Anne C Harttrampf, Ludovic Lacroix, Marc Deloger, et al.
Cancer
|
May 7, 2014
A phase 2 trial of R1507, a monoclonal antibody to the insulin-like growth factor-1 receptor (IGF-1R), in patients with recurrent or refractory rhabdomyosarcoma, osteosarcoma, synovial sarcoma, and other soft tissue sarcomas: results of a Sarcoma Alliance for Research Through Collaboration study
Alberto S Pappo, Gilles Vassal, John J Crowley, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
December 5, 2023
Phase I/II Study of the WEE1 Inhibitor Adavosertib (AZD1775) in Combination with Carboplatin in Children with Advanced Malignancies: Arm C of the AcSé-ESMART Trial
Susanne A Gatz, Anne C Harttrampf, Caroline Brard, et al.
Page
of 18